Welcome to AlterOnco, BraimIA, Drop, Emy, Frozmetics, IASO Discovery, Kahivac Therapeutics, Luminnov, Mantalys, Olea Medical, Oncoways, RNA Lead, SkinBionics, SunWaves Med Tech, Ultradoc, and VirtuBiopsy.
An AI assistant designed to save time and alleviate the mental burden of healthcare practitioners, a provider of advanced post-processing services for MR and CT perfusion imaging, an innovative digital platform dedicated to pediatric oncology, an immunopeptidomic platform to explore the 'dark genome' and design next-generation anti-cancer vaccines… no fewer than 16 innovative companies have just joined the Eurobiomed community.
AlterOnco
AlterOnco offers the development of an orchestration platform, dedicated to oncology, designed to automate all or part of patient management workflows.
BraimIA
Markus Santé is an AI Assistant designed to save time and alleviate the mental burden of healthcare practitioners. Developed with an Agentic AI approach, Markus-Santé is the transparent and reliable French AI solution for healthcare professionals. The BraimIA project has been under development for 2 years with a team of technical and business experts; a beta version is currently used by over 300 practitioners, and commercialization is scheduled for January 2026.
Drop
Drop is a project aimed at treating dry eye syndrome. The company proposes implementing a new process for accessing CSA (Autologous Serum Eye Drops) and innovative manufacturing procedures designed to standardize and facilitate the availability of this treatment, while simultaneously reducing its accessibility costs.
Emy
Emy is a mental health support application leveraging the latest French advancements in artificial intelligence (AI) to provide personalized, accessible, and affordable assistance. The application facilitates natural and fluid interactions, simulating a conversation with a close friend, family member, or healthcare professional (psychologist or psychiatrist). Emy positions itself as a true life companion, designed to support individuals navigating emotional challenges, whether minor or more significant.
Frozmetics
Frozmetics, a company founded in January 2023, aims to transform the approach to skin care and treatments by utilizing cold technologies and exclusively natural ingredients. Its objective is to modulate major deficient or diminished biological functions, particularly during skin aging, to restore optimal functioning.
IASO Discovery
IASO Discovery is a biotech specializing in early-stage drug discovery. It is developing an innovative platform for the discovery (design/synthesis) and optimization of therapeutic oligonucleotides, originating from the ARNA laboratory in Bordeaux, led by Professor Philippe Barthélémy, who is also a co-founder of the company. Its hybrid economic model combines service provision and co-development.
Kahivac Therapeutics
Kahivac Therapeutics is an innovative biotechnology startup project specializing in immuno-oncology. Its mission is the discovery and development of novel therapies to help patients recover from cancer and improve their quality of life. The company will develop a disruptive immunopeptidomic platform that will explore the 'dark genome' to design next-generation anti-cancer vaccines.
LumInnov
LumInnov is developing Sunlution, an innovative skincare brand that combines sun protection factor (SPF) with anti-aging and antioxidant properties. The technology relies on encapsulation and cell protection systems to enhance filter efficacy and absorb antioxidant active ingredients.
Mantalys
Mantalys is a Toulouse-based startup originating from public laboratories. It designs lightweight, fast, and high-performance AI solutions for image analysis, combining the power of deep learning with the elegance of evolutionary approaches. Its custom algorithms require minimal training data, are easily deployable, and have a low energy footprint. Furthermore, Mantalys develops an intuitive software suite integrating their proprietary models for advanced scientific analysis.
Olea Medical
As a provider of advanced post-processing services for MR and CT perfusion imaging, Olea Medical designs medical imaging applications that enhance diagnostic processes. Olea Medical's mission is to develop specialized software for optimizing medical images and diagnosis, primarily in the field of emergency neurology.
Oncoways
Oncoways is an innovative digital platform dedicated to pediatric oncology. It centralizes patient information to optimize their monitoring and care management in France. Through real-time care coordination, managed by the referring oncologist and enhanced by AI-driven data analysis alerts, Oncoways revolutionizes the management of treatment protocols for young cancer patients.
RNA Lead
The mission of RNALead is to provide its partners with a powerful, versatile, and proven proprietary RNA delivery technology. The company supports its clients throughout their innovation journey, from initial research phases to clinical applications, with a turnkey solution designed to meet the evolving demands of modern gene and cell therapies.
SkinBionics
SkinBionics is a digital health solution that assists physicians in detecting skin anomalies in vivo and in real-time. This is achieved through a non-diagnostic platform and device, based on the ABCDE methodology utilized by dermatologists.
SunWaves Med Tech
SunWaves MedTech is a French medical technology company specializing in AI-augmented medical supervision. Its SaaS platform combines digital biomarkers, certified connected devices, and artificial intelligence to provide 24/7 monitoring for fragile, chronic, or convalescing patients. SunWaves relies on its own medical supervision centers and employed medical teams to support care without replacing treating physicians.
Ultradoc
Ultradoc is developing an all-in-one connected medical device, enabling physicians to simultaneously measure multiple health data points (heart rate, respiration, oximetry, etc.) for a comprehensive and rapid diagnosis.
VirtuBiopsy
VirtuBiopsy is developing an AI algorithm for radiologists and oncologists. This solution combines the analysis of imaging results with the patient's metabolomic results for an effective diagnosis in cases of suspected cancer, thereby avoiding the need for conventional biopsy, which is invasive and sometimes painful.
